Alpine Immune Sciences Announces Participation in Fireside Chat at the 4th Annual Evercore ISI HealthCONx Conference

Rhea-AI Summary

Alpine Immune Sciences, Inc. (NASDAQ: ALPN) will participate in a fireside chat at the 4th Annual Evercore ISI HealthCONx Conference on December 1, 2021, at 12:35 p.m. ET. The event will be accessible via a live webcast on the company's investor relations page, with a replay available for 90 days post-event. Alpine focuses on developing innovative immunotherapies for cancer and autoimmune diseases, leveraging advanced protein engineering technologies. Collaborations with global biopharmaceutical companies enhance their diverse pipeline of clinical and preclinical candidates.

Positive

• Participation in the reputable Evercore ISI HealthCONx Conference, enhancing visibility.
• Commitment to innovative treatments for cancer and autoimmune diseases.
• Established collaborations with leading biopharmaceutical companies.

Negative

• None.

SEATTLE--(BUSINESS WIRE)-- Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, today announced the company will participate in a fireside chat at the 4th Annual Evercore ISI HealthCONx Conference on Wednesday, December 1^st, 2021, at 12:35 p.m. ET/9:35 a.m. PT.

A live webcast of the fireside chat will be available online in the investor relations section of the company’s website at https://ir.alpineimmunesciences.com/events. A replay of the presentation will be available on the company website for 90 days following the webcast.

About Alpine Immune Sciences, Inc.

Alpine Immune Sciences is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. For more information, visit www.alpineimmunesciences.com. Follow @AlpineImmuneSci on Twitter and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211122006333/en/

Alpine Immune Sciences, Inc.

Contacts:

Alex Sharif

Director, Investor Relations and Corporate Development

Alpine Immune Sciences, Inc.

206.788.4545

ir@alpineimmunesciences.com



Kelli Perkins (Media)

310.625.3248

kelli@redhousecomms.com

Source: Alpine Immune Sciences, Inc.

FAQ

When is Alpine Immune Sciences participating in the Evercore ISI HealthCONx Conference?

Alpine Immune Sciences will participate on December 1, 2021, at 12:35 p.m. ET.

Where can I watch the Alpine Immune Sciences fireside chat?

The fireside chat will be available as a live webcast on the company's investor relations website.

What is the focus of Alpine Immune Sciences' research?

Alpine Immune Sciences focuses on developing immunotherapies for cancer and autoimmune diseases.

How long will the replay of the Alpine Immune Sciences conference presentation be available?

The replay will be available for 90 days following the webcast.